-
ICD-10-CM Codes
›
-
C00-D49
Neoplasms
›
-
D3A-D3A
Benign neuroendocrine tumors
›
-
D3A-
Benign neuroendocrine tumors
›
-
2022 ICD-10-CM Diagnosis Code D3A.098
2022 ICD-10-CM Diagnosis Code D3A.098
Benign carcinoid tumors of other sites
2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
- D3A.098 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2022 edition of ICD-10-CM D3A.098 became effective on October 1, 2021.
- This is the American ICD-10-CM version of D3A.098 - other international versions of ICD-10 D3A.098 may differ.
The following code(s) above
D3A.098 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D3A.098:
ICD-10-CM D3A.098 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
Convert D3A.098 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
ICD-10-CM Codes Adjacent To D3A.098
D3A.026 Benign carcinoid tumor of the rectum
D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion
D3A.09 Benign carcinoid tumors of other sites
D3A.090 Benign carcinoid tumor of the bronchus and lung
D3A.091 Benign carcinoid tumor of the thymus
D3A.092 Benign carcinoid tumor of the stomach
D3A.093 Benign carcinoid tumor of the kidney
D3A.094 Benign carcinoid tumor of the foregut, unspecified
D3A.095 Benign carcinoid tumor of the midgut, unspecified
D3A.096 Benign carcinoid tumor of the hindgut, unspecified
D3A.098
Benign carcinoid tumors of other sites
D3A.8 Other benign neuroendocrine tumors
D37 Neoplasm of uncertain behavior of oral cavity and digestive organs
D37.0 Neoplasm of uncertain behavior of lip, oral cavity and pharynx
D37.01 Neoplasm of uncertain behavior of lip
D37.02 Neoplasm of uncertain behavior of tongue
D37.03 Neoplasm of uncertain behavior of the major salivary glands
D37.030 Neoplasm of uncertain behavior of the parotid salivary glands
D37.031 Neoplasm of uncertain behavior of the sublingual salivary glands
D37.032 Neoplasm of uncertain behavior of the submandibular salivary glands
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.